Yahoo Suche Web Suche

  1. Safeguard your pharmaceuticals with our patented powder transfer systems. Discover hi-tech solutions for pharma containment at ChargePoint Technology

Suchergebnisse

  1. Suchergebnisse:
  1. 23. Mai 2024 · About Us. Annual Report and Accounts 2023. Our Annual Report and Accounts 2023 is available to download. Download. Indivior's Nasdaq Listing and Campaign. Learn more. Latest News. May 23 2024. Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance. Read more. Latest Results. May 23 2024. Analyst Teach-in.

    • About Us

      About Us Indivior is a global pharmaceutical company working...

    • Our Science

      Our Science Our purpose is to provide life-transforming...

    • Products

      The product specific website that you have requested is...

  2. 20. Mai 2024 · A global biopharmaceutical company developing and commercializing innovative protein replacement therapies and precision medicines to serve the unserved rare disease patient. Read more. Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders. Corporate updates. May 21 2024. Read more.

  3. 24. Mai 2024 · Faron Pharmaceuticals is a clinical-stage biopharmaceutical company based in Finland and the United States, with a focus on developing bexmarilimab, a first-in-class, humanized antibody that binds the Clever-1 target on myeloid cells and macrophages.

  4. Vor 4 Tagen · May 28, 2024. Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024. Read more. See all press releases. Responsible Growth. We think broadly about our commitment to responsible environmental stewardship, and strive to reduce the impact of our operations on the environment.

  5. Vor 10 Stunden · June 7, 2024 at 2:08 AM PDT. Listen. 1:26. Denmark recorded its largest jump in industrial production in almost eight years, driven by a surge in output at Novo Nordisk A/S and the rest of the ...

  6. Vor 3 Tagen · Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include LUXTURNA (voretigene neparvovec) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy and viable retinal cells.

  7. 13. Mai 2024 · Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) made waves Monday afternoon not only with the announcement of its groundbreaking BioHive-2 supercomputer but also with a notable surge in its stock...